Vancouver biotech company AbCellera's IPO nets $556M | Venture
IPO Stock AbCellera Eyes Profitability As Covid-19 Antibody Sales Soar | Investor's Business Daily
Vancouver's AbCellera on hiring spree after smash IPO | Venture
AbCellera boosts IPO target second time in a week, seeking to raise US$483 - Technology | Business in Vancouver
IPO Alert: AbCellera Biologics (ABCL)
IPO: AbCellera Biologics
Abcellera Biologics Inc. | BioWorld
AI drug discovery platform AbCellera prices upsized IPO at $20, above the upwardly revised range - Renaissance Capital
COVID-19 roundup: AbCellera considering IPO as early as fall - The Logic
AbCellera IPO: Stock to Fund COVID Antibody Therapy
IPO Launch: AbCellera Biologics Readies $357 Million IPO - IPOs On TheStreet - U.S. IPO Research & Opinion
AbCellera Biologics's billionaire boss planning hiring spree in Vancouver hometown after record-setting IPO - : r/canada
Former PHAS professor Carl Hansen featured in media for successful AbCellera IPO | UBC Physics & Astronomy
Pre-IPO: Everything You Need To Know About AbCellera (Part I) (NASDAQ:ABCL) | Seeking Alpha
AbCellera IPO: Shares debut at US$20 in blockbuster bid for B.C. biotech - Technology | Business in Vancouver
Pre-IPO: Everything You Need To Know About AbCellera (Part I) (NASDAQ:ABCL) | Seeking Alpha
AbCellera, tapped by Lilly for its COVID-19 antibody therapy, sets IPO terms with $5B valuation | Fierce Biotech
IPO Launch: AbCellera Biologics Readies $357 Million IPO - IPOs On TheStreet - U.S. IPO Research & Opinion
DCVC Bio, Viking Global Investors backed AbCellera Biologics files for IPO on NASDAQ - Private Capital Journal
AbCellera - Products, Competitors, Financials, Employees, Headquarters Locations
AbCellera Biologics to raise up to US $391M from NASDAQ IPO at up to US $4.52B valuation - Private Capital Journal
